We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
-8.96%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$84.4M
AUM Growth
+$21.1M
Cap. Flow
+$32.2M
Cap. Flow %
38.14%
Top 10 Hldgs %
40.36%
Holding
205
New
40
Increased
46
Reduced
32
Closed
28

Sector Composition

Rank Sector Weight
1 Healthcare 16.45%
2 Financials 15.96%
3 Technology 9.45%
4 Communication Services 5.59%
5 Energy 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNOW icon
101
Snowflake
SNOW
$107B
$209K 0.25%
+1,500
New +$238K
AMD icon
102
Advanced Micro Devices
AMD
$790B
$208K 0.25%
2,718
-509
-16% -$47.6K
MMYT icon
103
MakeMyTrip
MMYT
$5.81B
$205K 0.24%
8,000
-3,500
-30% -$90.4K
TCON
104
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$200K 0.24%
5,000
+1,650
+49% +$63.9K
ADMA icon
105
ADMA Biologics
ADMA
$2.03B
$198K 0.23%
100,000
-132,500
-57% -$261K
VSTM icon
106
Verastem
VSTM
$500M
$197K 0.23%
14,167
+2,917
+26% +$46.5K
MNKD icon
107
MannKind Corp
MNKD
$1.17B
$190K 0.23%
+50,000
New +$184K
NTBL
108
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$190K 0.23%
3,371
+1,228
+57% +$67.1K
WBD icon
109
Warner Bros
WBD
$65.4B
$176K 0.21%
13,089
+4,089
+45% +$75.8K
GSAT icon
110
Globalstar
GSAT
$10.8B
$175K 0.21%
9,500
+833
+10% +$15.5K
ACRS icon
111
Aclaris Therapeutics
ACRS
$772M
$154K 0.18%
11,043
-7,968
-42% -$112K
GTYH
112
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$153K 0.18%
+24,500
New +$125K
ALT icon
113
Altimmune
ALT
$583M
$152K 0.18%
+13,000
New +$80.2K
FHLT
114
DELISTED
Future Health ESG Corp. Common stock
FHLT
$145K 0.17%
14,632
CFRX
115
DELISTED
ContraFect Corporation
CFRX
$141K 0.17%
575
-262
-31% -$74K
FRTX
116
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$137K 0.16%
24,111
-18,225
-43% -$165K
HGEN
117
DELISTED
HUMANIGEN, INC.
HGEN
$129K 0.15%
73,000
+6,500
+10% +$14.6K
STON
118
DELISTED
StoneMor Inc.
STON
$85K 0.1%
+24,851
New +$70.6K
BLPH
119
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$85K 0.1%
69,000
-14,584
-17% -$19.5K
ALLT icon
120
Allot
ALLT
$386M
$78K 0.09%
16,000
BKT icon
121
BlackRock Income Trust
BKT
$334M
$66K 0.08%
+4,833
New +$67.8K
MJ icon
122
Amplify Alternative Harvest ETF
MJ
$104M
$64K 0.08%
917
LONA
123
LeonaBio Inc
LONA
$70.2M
$46K 0.05%
+1,500
New +$137K
FHLTW
124
DELISTED
Future Health ESG Corp. Warrant
FHLTW
$43K 0.05%
149,885
-4
-0% -$1
CRHC.WS
125
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$43K 0.05%
100,000
-80,100
-44% -$58.3K

Similar funds

Telemetry Investments's Q2 2022 Portfolio in Review

As of Q2 2022, Telemetry Investments held 205 positions worth $84.4M, up 33% from $63.4M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Telemetry Investments deployed $32.2M of net new capital in Q2 2022, opening 40 new positions and adding to 46 existing holdings. Its largest new stake was CDK Global, Inc.: 20,500 shares worth $1.12M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 23% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was PowerUp Acquisition Corp. Unit, an estimated $492K trimmed.

  • Telemetry Investments's largest Q2 2022 buy was CDK Global, Inc.: 20,500 shares worth $1.12M.
  • Telemetry Investments added most to Freeport-McMoran in Q2 2022, an estimated $959K increase.
  • Telemetry Investments's biggest Q2 2022 reduction was PowerUp Acquisition Corp. Unit, cutting an estimated $492K.
  • Telemetry Investments fully exited People's United Financial Inc in Q2 2022, selling an estimated $1.49M.
  • Telemetry Investments's ten largest holdings make up 40% of its $84.4M portfolio in Q2 2022.
  • Telemetry Investments opened 40 new positions and closed 28 in Q2 2022.
  • Telemetry Investments's portfolio value rose 33% quarter-over-quarter to $84.4M.

Based on Telemetry Investments's 13F filing for Q2 2022, filed 15 Aug 2022.